Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
about
Microbial translocation in chronic liver diseasesMechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeabilityA mutation in the leptin receptor is associated with Entamoeba histolytica infection in children.Human nutrition, the gut microbiome and the immune systemThe Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundDietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseasesRole of the microbiome in non-gastrointestinal cancersInsulin resistance in development and progression of nonalcoholic fatty liver diseaseDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetRole of gut microbiota in the modulation of atherosclerosis-associated immune responseRole of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesityInvolvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesityContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)Gut-central nervous system axis is a target for nutritional therapiesIL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease ProgressionGut Microbiota: A Contributing Factor to ObesityToll-like receptors in pathophysiology of liver diseasesTargeting gut microbiota: a potential promising therapy for diabetic kidney diseaseThe role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetesGut Microbiota and Host Reaction in Liver DiseasesPossible links between intestinal permeability and food processing: A potential therapeutic niche for glutamineBoth systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammationTetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed miceIncreased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese miceChanges in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeabilityEvidence for the effects of yogurt on gut health and obesity.Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection.Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitisLeptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica.Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats.Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites.Pathogenesis of non-alcoholic fatty liver disease.High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ FunctionsRole of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice.Transcriptional profiles of leukocyte populations provide a tool for interpreting gene expression patterns associated with high fat diet in mice.Of microbes and meals: the health consequences of dietary endotoxemia.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)
P2860
Q21284997-6951E5FC-77BF-4B56-96D3-261548496CF7Q24317362-8D7A74EE-BEA8-4438-852A-B0B6E32899FBQ24608108-945B93A7-8E4F-41A2-8B45-18B25CC93054Q24620449-CFBF31CA-5F2F-454A-8AC3-AB1CEEA439A4Q26744380-20E32F25-9B14-41FD-8135-61F26AA5AF42Q26746677-AEA0DB9D-7FC9-46CA-9C04-6D8082997B94Q26747710-79C90365-B46C-4333-8826-D4DDF903C783Q26748687-DAC5737B-6965-4D95-8948-C5767F717ECCQ26752614-8C207E02-08E6-4516-96DE-204E523C6191Q26801649-682C6A7C-C59C-4A12-B243-962294FB5E14Q26802171-6E46B68A-2020-4A97-B293-17A6592D76EBQ26828547-10464BE7-3105-41AA-A799-3FA12453687CQ26992106-687ADA0A-9913-411F-A7FF-359C13C7AAABQ27007515-3AFFB027-8947-4D8B-ACEB-9EE81D34E08CQ27021781-0A83B69D-60DB-43A5-987F-72C66F79E618Q27025620-F9EC6BF4-EF51-4C42-8BD6-391818B11E1AQ28066301-989858E2-E79D-41D8-978B-B34470102417Q28070077-0C9A8518-68C8-477D-BA18-97744260AE0FQ28078235-A0D0B4B1-D75C-4400-92F2-09A4A376BC04Q28080912-3C723437-BB8D-485F-A1F4-BE352F4E61A1Q28083295-CF6FE1B8-1188-4861-BEFC-A6ADB7E77318Q28287402-6033D83B-B96B-41F7-801C-0F2A854A8CA6Q28389532-81DFF778-D3FC-4266-8D70-2963EA728AD1Q28730877-EF2F2D8B-A1DE-4E85-B236-450679989F23Q28730963-BEAC20B1-7576-443B-89D4-BC6952B2D0FBQ29617378-23D241E8-DA10-4042-93BF-23554BC144F6Q30252163-C2420CCD-BE87-4858-B055-1FE62A2A0517Q30300874-1E00B4B4-A7E6-4756-BCC1-508EFB4AD32DQ30412148-25DB4430-A5D3-4B31-BA4E-147EC8AE67DEQ30430038-A246178F-15C4-498A-8F68-B2443C99050AQ30983737-7E2A677D-CC05-4C74-A274-0D0D52FF1911Q31113843-505C26D7-F7BB-4A41-819C-6EF07F951088Q31142368-4FBD5524-3832-4399-9D13-C31824CB4316Q33558610-6685B8EA-6986-4203-A031-DCD0E2F2B1DCQ33606303-1BF35C5A-5FAD-4B82-AAEB-0CF24F9B2A35Q33616618-D12E4F53-1E90-4DB8-8A71-427DE939E3FCQ33645106-A15651EF-D57B-4F20-A83D-4A43DAAD0F49Q33649678-DE4002B5-A4D1-4DCE-AB3B-5E066612B582Q33713662-F91D7FAC-97D9-480F-A122-73A3F5643F2CQ33755566-9CEA2572-9A33-45A0-9C32-7D1990E85F06
P2860
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Increased intestinal permeabil ...... nonalcoholic steatohepatitis.
@en
type
label
Increased intestinal permeabil ...... nonalcoholic steatohepatitis.
@en
prefLabel
Increased intestinal permeabil ...... nonalcoholic steatohepatitis.
@en
P2093
P921
P356
P1476
Increased intestinal permeabil ...... nonalcoholic steatohepatitis.
@en
P2093
Andrea Buda
Diego Martines
Ignazio Castagliuolo
Massimo Pinzani
Paola Brun
Vincenza Di Leo
P304
P356
10.1152/AJPGI.00024.2006
P50
P577
2006-10-05T00:00:00Z